
    
      Results from the Atlas Genetics ioÂ® system are compared with a Composite Infection Status
      obtained from testing on three commonly used comparator devices.

      This is a prospective, single-arm, multi-centre investigation enrolling up to 12,000 adult
      participants over 14 years of age who are undergoing testing for the presence of CT/NG.
    
  